July 28, 2014 12:54 AM ET


Company Overview of Nerium Biotechnology, Inc

Company Overview

Nerium Biotechnology, Inc., a biotechnology company, engages in the development of oleander-based products for the treatment of certain forms of proliferative diseases and viral infections. Its lead product includes Anvirzel, which is used to treat various forms of cancer. The company’s product line also comprises HIviral for the treatment of HIV/AIDS; HEP-viral for the treatment of hepatitis C; and NeriumAD, a skin cream for age-defying treatment. Nerium Biotechnology, Inc. is based in San Antonio, the United States.

11467 Huebner Road

Suite 175

San Antonio, TX 78230

United States



Key Executives for Nerium Biotechnology, Inc

Age: 63
Chief Financial Officer
Age: 57
Compensation as of Fiscal Year 2014.

Nerium Biotechnology, Inc Key Developments

Nerium Biotechnology, Inc Appoints Richard Boxer as Director

Nerium Biotechnology Inc. announced that its Board of Directors has met and made the following resolutions, Mr. Richard Boxer of Toronto, Canada has been appointed as a director of NBI and the number of directors has been increased from six to seven. Mr. Boxer has extensive experience with business and community organizations in both the "for profit" and "not for profit" sectors and has served in numerous capacities on various boards and committees.

Nerium Biotechnology, Inc, Annual General Meeting, Jun 25, 2014

Nerium Biotechnology, Inc, Annual General Meeting, Jun 25, 2014., at 10:00 Eastern Daylight. Location: Tthe law office of Stikeman Keeley Spiegel Pasternack LLP, 200 Front Street Wes. Agenda: To receive the audited consolidated financial statements of the company for the year ended December 31, 2013, together with the report of the auditors thereon; to elect directors of the company for the ensuing year; to re-appoint auditors and to authorize the directors to fix their remuneration; and to transact such further or other business as may properly come before the meeting or any adjournment or adjournments thereof.

Nerium Biotechnology, Inc Proposes New General By-Law

Nerium Biotechnology Inc. will consider the proposal to confirm a new general by-law for the company at AGM to be held on June 27, 2013.

Similar Private Companies By Industry

Company Name Region
Cytomyx LLC United States
ISTO Technologies, Inc. United States
SABiosciences Corporation United States
Stem Cell Innovations, Inc. United States
CDG Therapeutics, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Nerium Biotechnology, Inc, please visit www.nerium.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.